Genetic polymorphisms of the IFNλ genes are associated with biochemical features in Han Chinese with HCV infection from Yunnan Province, China

Infection, Genetics and Evolution

Volumn 21, Issue , 2014, Pages 161-165

  Zhang, A Mei ^a   Ma, Ke ^a   Song, Yuzhu ^a   Wang, Binghui ^a   Feng, Yue ^a   Liu, Li ^a   Xia, Xueshan ^a  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Biochemical features; Chinese; HCV infection; IFN genes; Variations

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GENOMIC DNA; INTERLEUKIN 28A; INTERLEUKIN 28B; INTERLEUKIN 29; VIRUS RNA; IL28A PROTEIN, HUMAN; IL28B PROTEIN, HUMAN; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; VIRUS PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CHINA; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HAN CHINESE; HAPLOTYPE; HEPATITIS C; HUMAN; IL28A GENE; IL28B GENE; IL29 GENE; INTERFERON LAMBDA GENE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; BLOOD; GENETICS; HEPACIVIRUS; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

BILIRUBIN; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERLEUKINS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; VIRAL PROTEINS;

EID: 84888791982     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.11.013     Document Type: Article

References (35)

1. Agundez J.A., Garcia-Martin E., Maestro M.L., Cuenca F., Martinez C., Ortega L., et al. Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease. PLoS One 2012, 7:e37998.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Cheng H.R., Liu C.J., Tseng T.C., Su T.H., Yang H.I., Chen C.J., et al. Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients. PLoS One 2013, 8:e53008.
4. Dellgren C., Gad H.H., Hamming O.J., Melchjorsen J., Hartmann R. Human interferon-lambda3 is a potent member of the type III interferon family. Genes Immun. 2009, 10:125-131.
5. Deng L., Adachi T., Kitayama K., Bungyoku Y., Kitazawa S., Ishido S., et al. Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J. Virol. 2008, 82:10375-10385.
6. Ding S., Chen B., Zheng Y., Lu Q., Liu L., Zhuge Q.C. Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. BMC Psychiatry 2013, 13:107.
7. Dolganiuc A., Kodys K., Marshall C., Saha B., Zhang S., Bala S., et al. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS One 2012, 7:e44915.
8. Erdtmann L., Franck N., Lerat H., Le Seyec J., Gilot D., Cannie I., et al. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J. Biol. Chem. 2003, 278:18256-18264.
9. Friborg J., Levine S., Chen C., Sheaffer A.K., Chaniewski S., Voss S., et al. Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication. Antimicrob. Agents Chemother. 2013, 57:1312-1322.
10. Gad H.H., Dellgren C., Hamming O.J., Vends S., Paludan S.R., Hartmann R. Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J. Biol. Chem. 2009, 284:20869-20875.
11. Ge D., Fellay J., Thompson A.J., Simon J.S., Shianna K.V., Urban T.J., et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401.
12. Hoofnagle J.H. Course and outcome of hepatitis C. Hepatology 2002, 36:S21-29.
13. Ji Y., Zhang A.-M., Jia X., Zhang Y.-P., Xiao X., Li S., et al. Mitochondrial DNA haplogroups M7b1'2 and M8a affect clinical expression of leber hereditary optic neuropathy in Chinese families with the m.11778G → mutation. Am. J. Hum. Genet. 2008, 83:760-768.
14. Kohli A., Zhang X., Yang J., Russell R.S., Donnelly R.P., Sheikh F., et al. Distinct and overlapping genomic profiles and antiviral effects of interferon-lambda and -alpha on HCV-infected and noninfected hepatoma cells. J. Viral Hepat. 2012, 19:843-853.
15. Lane J., McLaren P.J., Dorrell L., Shianna K.V., Stemke A., Pelak K., et al. A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum. Mol. Genet. 2013, 22:1903-1910.
16. Laplana M., Caruz A., Pineda J.A., Puig T., Fibla J. Association of BST-2 gene variants with HIV disease progression underscores the role of BST-2 in HIV type 1 infection. J. Infect. Dis. 2013, 207:411-419.
17. Li W., Huang X., Tong H., Wang Y., Zhang T., Wang W., et al. Comparison of the regulation of beta-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells. PLoS One 2012, 7:e47040.
18. Liu M.Q., Zhou D.J., Wang X., Zhou W., Ye L., Li J.L., et al. IFN-lambda3 inhibits HIV infection of macrophages through the JAK-STAT pathway. PLoS One 2012, 7:e35902.
19. Lu L., Nakano T., He Y., Fu Y., Hagedorn C.H., Robertson B.H. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J. Med. Virol. 2005, 75:538-549.
20. Mangia A., Santoro R., Copetti M., Massari M., Piazzolla V., Spada E., et al. Treatment optimization of and prediction of HCV clearance in patients with acute HCV infection. J. Hepatol. 2013, 59:221-228.
21. Marukian S., Andrus L., Sheahan T.P., Jones C.T., Charles E.D., Ploss A., et al. Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 2011, 54:1913-1923.
22. Micallef J.M., Kaldor J.M., Dore G.J. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J. Viral Hepat. 2006, 13:34-41.
23. Morgan T.R., Lambrecht R.W., Bonkovsky H.L., Chung R.T., Naishadham D., Sterling R.K., et al. DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J. Hepatol. 2008, 49:548-556.
24. Nakano R., Maekawa T., Abe H., Hayashida Y., Ochi H., Tsunoda T., et al. Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis C. J. Gen. Virol. 2013, 94:81-89.
25. Schaefer E.A., Chung R.T. Anti-hepatitis C virus drugs in development. Gastroenterology 2012, 142(1340-1350):e1341.
26. Shi X., Pan Y., Wang M., Wang D., Li W., Jiang T., et al. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One 2012, 7:e37054.
27. Stephens M., Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 2003, 73:1162-1169.
28. Suppiah V., Moldovan M., Ahlenstiel G., Berg T., Weltman M., Abate M.L., et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat. Genet. 2009, 41:1100-1104.
29. Tanaka Y., Nishida N., Sugiyama M., Kurosaki M., Matsuura K., Sakamoto N., et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet. 2009, 41:1105-1109.
30. Thomas D.L., Seeff L.B. Natural history of hepatitis C. Clin. Liver Dis. 2005, 9:383-398.
31. Thomas D.L., Thio C.L., Martin M.P., Qi Y., Ge D., O'Huigin C., et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, 461:798-801.
32. Uze G., Monneron D. IL-28 and IL-29: newcomers to the interferon family. Biochimie 2007, 89:729-734.
33. Younossi Z.M., Birerdinc A., Estep M., Stepanova M., Afendy A., Baranova A. The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. J. Transl. Med. 2012, 10:25.
34. Zhang D.-F., Huang X.-Q., Wang D., Li Y.-Y., Yao Y.-G. Genetic variants of complement genes ficolin-2, mannose-binding lectin and complement factor H are associated with leprosy in Han Chinese from Southwest China. Hum. Genet. 2013, 132:629-640.
35. Zhang L., Jilg N., Shao R.X., Lin W., Fusco D.N., Zhao H., et al. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. J. Hepatol. 2011, 55:289-298.